entity

MARK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MARK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections

30Hypotheses

0Analyses

2Outgoing

0Incoming

8Experiments

0Debates

No AI portrait yet

Wiki Pages (7)

Knowledge base pages for this entity

Canonical Page

Outgoing (2)

Target	Relation	Type	Str
TAU	phosphorylates	protein	0.95
MAPT	phosphorylates	protein	0.90

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Ketone Utilization Index as Metabolic Flexibility Biomarker	0.819	translational neuroscience	Which metabolic biomarkers can distingui
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind	0.801	neuroimmunology	TREM2 in Alzheimer's Disease: Mechanisms
Integrated Biomarker Panel for Therapeutic Window Identifica	0.784	neurodegeneration	What are the precise temporal dynamics o
sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy	0.757	neurodegeneration	View
tight-junction remodeling is the actionable driver in: Blood	0.750	neurodegeneration	Blood-brain barrier permeability changes

plasma GFAP separates causal from compensatory states in: Bl	0.738	neurodegeneration	Blood-brain barrier permeability changes
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in	0.735	Alzheimer's disease	TREM2 agonism vs antagonism in DAM micro
p16^INK4a-CCF Axis as Senolytic Timing Biomarker	0.725	molecular biology	What is the optimal therapeutic window t
endothelial transcytosis defines the therapeutic window for:	0.723	neurodegeneration	Blood-brain barrier permeability changes
CSF YKL-40 as a Priming-Specific Chitinase Marker	0.710	biomarkers	What biomarkers can reliably detect micr
TDP-43 condensation thermodynamics as a therapeutic target a	0.710	neuroscience	How can subcellular compartmentalization
Creatine Kinase System Capacity as Neural Energy Reserve Bio	0.707	translational neuroscience	Which metabolic biomarkers can distingui
Pericyte-targeted senolysis or senomorphic therapy will bene	0.700	neurodegeneration	Does pericyte senescence drive BBB break
mTORC1 Reactivation as Autophagy-Senescence Divergence Point	0.685	molecular biology	What is the optimal therapeutic window t
Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification	0.677	translational neuroscience	Which metabolic biomarkers can distingui
Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR-	0.662	-	Blood-brain barrier permeability changes
TREM2-Driven Senescence Biomarker Index for Predicting Neuro	0.642	neurodegeneration	Gene expression changes in aging mouse b
Retromer-dependent retrograde endosomal signaling compartmen	0.620	neuroscience	How can subcellular compartmentalization
CSF Biomarker-Guided ABCA7 Therapeutic Dosing	0.619	neurodegeneration	Why does the V1613M variant reduce amylo
Neurovascular Permeability Score (NVPS): Composite Plasma +	0.600	-	Blood-brain barrier permeability changes
GFAP Perivascular Redistribution (End-Feet Retraction) as Tr	0.594	-	Blood-brain barrier permeability changes
Autophagy-Epigenetic Feedback Loop Creates a Compounding Bio	0.583	-	Epigenetic clocks as biomarkers for Alzh
A lower trazodone dose of 50-100 mg nightly may be sufficien	0.580	neurodegeneration	-
Dynamic Microglial Phenotype Switching Biomarker Panel for N	0.577	neurodegeneration	What amyloid threshold level is required
Purine Salvage Pathway Flux as Neuroprotection Efficacy Mark	0.565	translational neuroscience	Which metabolic biomarkers can distingui
Real-time closed-loop transcranial focused ultrasound target	0.542	Alzheimer's disease	Circuit-level neural dynamics in neurode
A genetically encoded reporter for axonal mitochondrial prot	0.540	neuroscience	How can subcellular compartmentalization
Multi-Biomarker Composite Index Surpassing Amyloid PET for T	0.535	neurodegeneration	What amyloid threshold level is required
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio	0.532	translational neuroscience	Which metabolic biomarkers can distingui
Basal cGAS Derepression as Stratification Biomarker	0.520	neurodegeneration	What determines the specificity of TDP-4

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (8)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
AECII-specific HMGCS2 overexpression in mouse pulmonary fibrosis	validation	idiopathic pulmonary fibrosis	0.950	C57BL/6 mice with AECII-specif	proposed	N/A
Ketogenic diet fat threshold analysis in wild-type mice	validation	metabolic disease	0.900	C57BL/6J wild-type mice	proposed	N/A
HMGCS2 gain-of-function in AECII lipid metabolism regulation	exploratory	idiopathic pulmonary fibrosis	0.900	human AECIIs	proposed	N/A
Ketogenic diet efficacy in diet-induced obese mice	validation	obesity, metabolic disease	0.900	C57BL/6J diet-induced obese mi	proposed	N/A
Autophagy receptor identification for stress granule elimination	exploratory	neurodegenerative diseases	0.900	cultured cells under arsenite	proposed	N/A
Chi3l1 deletion effects on baseline glial activation in mice	validation	baseline neuroinflammation	0.900	Chi3l1 knockout mice	proposed	N/A
Microarray and single-cell RNA analysis of lipid metabolism genes	exploratory	idiopathic pulmonary fibrosis	0.850	human patients, mouse models	proposed	N/A
CHI3L1 variant association with AD progression in human patients	exploratory	Alzheimer's disease	0.850	human patients	proposed	N/A

Related Papers (16)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745]	Yu CH, Davidson S, Harapas CR, Hilton JB	Cell	2020	2
Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159]	Padilla CM, Lafyatis R, Gibson KF, Morse	Arthritis Care Res (Hoboken)	2026	0
Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940]	Zhu S, An D, Liu X	Sleep Med	2026	0
SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346]	Kök Kendirlioğlu B, Çörekli Kaymakçı E,	J Affect Disord	2026	0
Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627]	Ivanova T, Kazakova M, Dikov D, Dzhambov	Cells	2026	0
Correction: CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneratio [PMID:41699333]	Mushtaq Umar; Seh Bilal Ahmad; Khanday F	Molecular Neurobiology	2026	0
UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413]	Yang H, Li Y, Su J, Zhang H, Zhu W et al	Front Immunol	2026	0
Association of Alzheimer's disease progression with YKL40 levels in peripheral b [PMID:41725729]	Yang Q, Wang R, Pei J, Fu Q, Zhan Y et a	Front Neurol	2026	0
Constitutive neuronal expression and disease-associated upregulation of chitinas [PMID:41762671]	Gaur N, Angerer C, Gunes ZI, Ancau M, Wa	Brain	2026	0
Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologi [PMID:41953284]	Schneider R, Brand-Arzamendi K, Lim TR,	BMJ Neurol Open	2026	0
Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714]	Garton T, Gadani SP, Gill AJ, Calabresi	Neuron	2024	0
STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778]	Woo MS, Mayer C, Binkle-Ladisch L, Sonne	Cell	2024	0
Air pollution, glymphatic impairment, and Alzheimer's disease. [PMID:37777345]	Hussain R, Graham U, Elder A, Nedergaard	Trends in neurosciences	2023	0
Roles of neuropathology-associated reactive astrocytes: a systematic review. [PMID:36915214]	Lawrence JM, Schardien K, Wigdahl B, Non	Acta neuropathologica communic	2023	0
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977]	Neel DV, Basu H, Gunner G, Bergstresser	Neuron	2023	0
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced m [PMID:29400714]	Shi Y, Lin S, Staats KA, Li Y, Chang WH,	Nature medicine	2018	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning MARK in their description or question text

plasma GFAP separates causal from compensatory states in: Blood-brain barrier pe

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on plasma GFAP can distinguish harmful mechanisms from protective adaptation. Th

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

p16^INK4a-CCF Axis as Senolytic Timing Biomarker

Score: 0.725 · molecular biology · 2026-04-21

**Molecular Mechanism and Rationale** The p16^INK4a-CCF axis represents a sophisticated temporal biomarker system that

endothelial transcytosis defines the therapeutic window for: Blood-brain barrier

Score: 0.723 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing endothelial transcytosis with pericyte-protective dos

CSF YKL-40 as a Priming-Specific Chitinase Marker

Score: 0.710 · biomarkers · 2026-04-22

## Mechanistic Overview CSF YKL-40 as a Priming-Specific Chitinase Marker starts from the claim that modulating CHI3L1/Y

TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nuc

Score: 0.710 · neuroscience · 2026-04-26

FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytopla

Creatine Kinase System Capacity as Neural Energy Reserve Biomarker

Score: 0.707 · translational neuroscience · 2026-04-16

## Mechanistic Overview Creatine Kinase System Capacity as Neural Energy Reserve Biomarker starts from the claim that mo

Pericyte-targeted senolysis or senomorphic therapy will benefit only an early bi

Score: 0.700 · neurodegeneration · 2026-04-25

Therapeutic benefit from pericyte-directed senescence interventions depends on stage. If BBB leak and dysfunction occur

mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker

Score: 0.685 · molecular biology · 2026-04-21

## Mechanistic Overview mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker starts from the claim that m

Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker

Score: 0.677 · translational neuroscience · 2026-04-16

## Mechanistic Overview Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker starts from the claim tha

Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR-β as Sentinel Event

Score: 0.662 · unknown disease · 2026-04-26

CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau path

TREM2-Driven Senescence Biomarker Index for Predicting Neurodegeneration Risk

Score: 0.642 · neurodegeneration · 2026-04-20

**Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) pathway represents a

Retromer-dependent retrograde endosomal signaling compartmentalization as biomar

Score: 0.620 · neuroscience · 2026-04-26

VPS26/VPS29/VPS35 retromer complex maintains axonal endosomal signaling microdomains controlling TrkB/p75NTR trafficking

CSF Biomarker-Guided ABCA7 Therapeutic Dosing

Score: 0.619 · neurodegeneration · 2026-04-14

## **Molecular Mechanism and Rationale** ABCA7 (ATP-binding cassette transporter A7) functions as a critical lipid effl

Neurovascular Permeability Score (NVPS): Composite Plasma + Imaging Biomarker Pa

Score: 0.600 · unknown disease · 2026-04-26

A LASSO-optimized composite score integrating plasma GFAP, S100B, NFL, soluble PDGFR-β, and claudin-5 fragments to achie